{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:19:53Z","timestamp":1790745593368,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Despite scaling-up testing and antiretroviral treatment in Latin America, advanced HIV remains a significant public health problem. The objective of the present study was look for historical risk factors for death in French Guiana\u2019s HIV cohort taking into account the immunological status, the main opportunistic infections, and their treatment. A retrospective cohort study was conducted on data collected between 1992 and 2008 to identify factors associated with death in a cohort 2323 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 370 deaths for a total 9608 patient-years. Being on tuberculosis treatment was associated with a greater hazard of death. The diagnosis of confirmed tuberculosis, of histoplasmosis, of toxoplasmosis, and pneumocystosis were independently associated with death. Interactions terms between cotrimoxazole treatment and pneumocystosis, or between confirmed tuberculosis and tuberculosis treatment showed a protective treatment-effect. All patients having received anti-tuberculosis treatment (n\u2009=\u2009347) did not have a final diagnosis of tuberculosis (n\u2009=\u200993). For histoplasmosis, 199 patients received antifungal treatment while 141 were diagnosed as having histoplasmosis. The number of patients on anti-tuberculosis drugs was far greater that the number of patients with confirmed tuberculosis, and these patients on treatment without confirmed tuberculosis had a twofold greater risk of dying.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-020-05054-w","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T11:03:47Z","timestamp":1586516627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["HIV patients dying on anti-tuberculosis treatment: are undiagnosed infections still a problem in French Guiana?"],"prefix":"10.1186","volume":"13","author":[{"given":"Mathieu","family":"Nacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Djossou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Demar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Epelboin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Couppi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"5054_CR1","doi-asserted-by":"publisher","first-page":"e0006802","DOI":"10.1371\/journal.pntd.0006802","volume":"12","author":"M Nacher","year":"2018","unstructured":"Nacher M, Blanchet D, Bongomin F, Chakrabarti A, Couppi\u00e9 P, Demar M, et al. Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: a systematic review of diagnostic accuracy studies. PLoS Negl Trop Dis. 2018;12:e0006802. https:\/\/doi.org\/10.1371\/journal.pntd.0006802.","journal-title":"PLoS Negl Trop Dis"},{"key":"5054_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/jof5030073","volume":"5","author":"DH Caceres","year":"2019","unstructured":"Caceres DH, Valdes A. Histoplasmosis and tuberculosis co-occurrence in people with advanced HIV. J Fungi. 2019;5:73. https:\/\/doi.org\/10.3390\/jof5030073.","journal-title":"J Fungi"},{"key":"5054_CR3","doi-asserted-by":"publisher","first-page":"e2319","DOI":"10.1371\/journal.pntd.0002319","volume":"7","author":"M Nacher","year":"2013","unstructured":"Nacher M, Adenis A, Mc Donald S, Gomes MD, Singh S, Lopes IL, et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013;7:e2319. https:\/\/doi.org\/10.1371\/journal.pntd.0002319.","journal-title":"PLoS Negl Trop Dis"},{"key":"5054_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4269\/ajtmh.13-0084","volume":"90","author":"A Adenis","year":"2014","unstructured":"Adenis A, Nacher M, Hanf M, Basurko C, Dufour J, Huber F, et al. Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. Am J Trop Med Hyg. 2014;90:216\u201323. https:\/\/doi.org\/10.4269\/ajtmh.13-0084.","journal-title":"Am J Trop Med Hyg"},{"key":"5054_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1473-3099(18)30354-2","volume":"18","author":"AA Adenis","year":"2018","unstructured":"Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18:1150\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(18)30354-2.","journal-title":"Lancet Infect Dis"},{"key":"5054_CR6","unstructured":"Sterling T. Culture negative TB is associated with increased mortality in HIV-infected persons. 2015."},{"key":"5054_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.micinf.2005.09.009","volume":"8","author":"V Guernier","year":"2006","unstructured":"Guernier V, Gu\u00e9gan J-F, Deparis X. An evaluation of the actual incidence of tuberculosis in French Guiana using a capture-recapture model. Microbes Infect. 2006;8:721\u20137. https:\/\/doi.org\/10.1016\/j.micinf.2005.09.009.","journal-title":"Microbes Infect"},{"key":"5054_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4269\/ajtmh.2011.10-0251","volume":"84","author":"M Nacher","year":"2011","unstructured":"Nacher M, Adenis A, Adriouch L, Dufour J, Papot E, Hanf M, et al. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg. 2011;84:239\u201340. https:\/\/doi.org\/10.4269\/ajtmh.2011.10-0251.","journal-title":"Am J Trop Med Hyg"},{"key":"5054_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/jof5020051","volume":"5","author":"M Nacher","year":"2019","unstructured":"Nacher M, Leitao TS, G\u00f3mez BL, Couppi\u00e9 P, Adenis A, Damasceno L, et al. The fight against HIV-associated disseminated histoplasmosis in the Americas: unfolding the different stories of four centers. J Fungi. 2019;5:51. https:\/\/doi.org\/10.3390\/jof5020051.","journal-title":"J Fungi"},{"key":"5054_CR10","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1371\/journal.pntd.0003100","volume":"8","author":"A Adenis","year":"2014","unstructured":"Adenis A, Nacher M, Hanf M, Vantilcke V, Boukhari R, Blachet D, et al. HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority. PLoS Negl Trop Dis. 2014;8:e3100. https:\/\/doi.org\/10.1371\/journal.pntd.0003100.","journal-title":"PLoS Negl Trop Dis"},{"key":"5054_CR11","doi-asserted-by":"publisher","unstructured":"Huber F, Nacher M, Aznar C, Pierre-Demar M, El Guedj M, Vaz T, et al. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25\u00a0years experience of French Guiana: AIDS. 2008;22: 1047\u20131053. https:\/\/doi.org\/10.1097\/qad.0b013e3282ffde67.","DOI":"10.1097\/qad.0b013e3282ffde67"},{"key":"5054_CR12","doi-asserted-by":"publisher","first-page":"e2638","DOI":"10.1371\/journal.pntd.0002638","volume":"8","author":"M Nacher","year":"2014","unstructured":"Nacher M, Adenis A, Blanchet D, Vantilcke V, Demar M, Basurko C, et al. Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana. PLoS Negl Trop Dis. 2014;8:e2638. https:\/\/doi.org\/10.1371\/journal.pntd.0002638.","journal-title":"PLoS Negl Trop Dis"},{"key":"5054_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","volume":"60","author":"G Heinze","year":"2018","unstructured":"Heinze G, Wallisch C, Dunkler D. Variable selection-a review and recommendations for the practicing statistician. Biom J. 2018;60:431\u201349. https:\/\/doi.org\/10.1002\/bimj.201700067.","journal-title":"Biom J"},{"key":"5054_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0956462413516299","volume":"25","author":"V Vantilcke","year":"2014","unstructured":"Vantilcke V, Boukhari R, Jolivet A, Vautrin C, Misslin C, Adenis A, et al. Fever in hospitalized HIV-infected patients in Western French Guiana: first think histoplasmosis. Int J STD AIDS. 2014;25:656\u201361. https:\/\/doi.org\/10.1177\/0956462413516299.","journal-title":"Int J STD AIDS"},{"key":"5054_CR15","unstructured":"WHO| Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. In: WHO [Internet]. [cited 15 Oct 2019]. http:\/\/www.who.int\/hiv\/pub\/guidelines\/advanced-HIV-disease\/en\/."},{"key":"5054_CR16","unstructured":"Bressy J. Prise en charge du VIH - Recommandations du groupe d\u2019experts. In: Conseil national du sida et des h\u00e9patites virales [Internet]. 6 Aug 2019 [cited 14 Nov 2019]. https:\/\/cns.sante.fr\/actualites\/prise-en-charge-du-vih-recommandations-du-groupe-dexperts\/."},{"key":"5054_CR17","doi-asserted-by":"publisher","first-page":"e0197990","DOI":"10.1371\/journal.pone.0197990","volume":"13","author":"M Nacher","year":"2018","unstructured":"Nacher M, Adriouch L, Huber F, Vantilcke V, Djossou F, Elenga N, et al. Modeling of the HIV epidemic and continuum of care in French Guiana. PLoS ONE. 2018;13:e0197990. https:\/\/doi.org\/10.1371\/journal.pone.0197990.","journal-title":"PLoS ONE"},{"key":"5054_CR18","unstructured":"Article - Bulletin \u00e9pid\u00e9miologique hebdomadaire. http:\/\/beh.santepubliquefrance.fr\/beh\/2020\/2-3\/2020_2-3_2.html."}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05054-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T19:32:11Z","timestamp":1617996731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05054-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5054"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05054-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-15722\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-15722\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients included in the FHDH give written informed consent for the use of their data for research and publication of research results. Their identity is encrypted before sending the data to the Institut National de la Recherche M\u00e9dicale (INSERM), which centralizes data from Regional Coordination for the fight against HIV (COREVIH) throughout France. This cohort was approved by the Commission Nationale Informatique et Libert\u00e9s (CNIL) since Nov 27th 1991 and has led to numerous international scientific publications.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}